Stereotaxis Inc (STXS) Stock Price, Quote & News

Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is design...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 314 678 6100

Website: www.stereotaxis.com

Address:

710 North Tucker Boulevard, Suite 110, Saint Louis, United States

alexpitti Aug. 1 at 4:13 PM

I believe Stereotaxis will be utilizing AI to help procedures in about 3 years which creates a competitive edge versus manual procedures. $STXS

2 · Reply

alexpitti Aug. 1 at 3:47 PM

I believe $STXS will get GenesisX FDA approved in a few weeks and MAGiC FDA approved in 2 months.

0 · Reply

RemitTekram Aug. 1 at 1:38 PM

$STXS Adding...

0 · Reply

alexpitti Jul. 31 at 9:24 PM

Welcome to hell $ABEO $DCTH $STXS $MYO

0 · Reply

Eddypgil Jul. 30 at 8:12 PM

$STXS you could have sold the stock for $6 in 2021 when GenesisX was first announced and bought it today for $2.40

2 · Reply

Eddypgil Jul. 30 at 6:27 PM

$STXS what is last years acquisition APT up to this year?

0 · Reply

Ratman44 Jul. 30 at 4:02 PM

$STXS what is the probability of the first installation and first use of Genesis X to be announced with earnings? The tweet it was shipped was 6/20. Depending on the shipping method it could be at its destination already or should be arriving shortly. Then it depends on the hospital and if it is ready for installation, which I suppose it should be.

0 · Reply

BillyBeavers Jul. 30 at 3:13 PM

$STXS Why's a $20 stock still on sale for $2

1 · Reply

DecoderRing Jul. 29 at 11:17 PM

$STXS At this point I think even with real earnings whoever they pissed off will still turn on the short algos around 11AM. Honestly only option at this point for DAFNA to make good on its investment is to take it all private at $3.50, get the work done and then re-IPO in 5 years.

0 · Reply

alexpitti Jul. 29 at 11:12 PM

how bad will this earning season be for me? $STXS already pre-announced essentially $DCTH $ABEO $VF $MYO

1 · Reply

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

Jul 23, 2025, 8:00 AM EDT - 11 days ago

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 17, 2025, 8:32 AM EDT - 17 days ago

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

Jul 6, 2025, 2:13 AM EDT - 4 weeks ago

Stereotaxis: Recurring Revenue Inflection

Jul 1, 2025, 9:00 AM EDT - 4 weeks ago

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

May 12, 2025, 7:04 PM EDT - 2 months ago

Stereotaxis, Inc. (STXS) Q1 2025 Earnings Call Transcript

May 12, 2025, 4:01 PM EDT - 2 months ago

Stereotaxis Reports 2025 First Quarter Financial Results

Apr 22, 2025, 7:00 AM EDT - 3 months ago

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

Apr 21, 2025, 8:00 AM EDT - 3 months ago

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

Mar 19, 2025, 8:01 AM EDT - 4 months ago

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

Mar 10, 2025, 8:02 AM EDT - 5 months ago

Stereotaxis to Present at 37th Annual Roth Conference

Mar 7, 2025, 9:10 AM EST - 5 months ago

Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn

Mar 3, 2025, 10:34 AM EST - 5 months ago

Stereotaxis, Inc. (STXS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 7:32 AM EST - 5 months ago

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

Mar 3, 2025, 7:31 AM EST - 5 months ago

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

Mar 3, 2025, 7:30 AM EST - 5 months ago

Stereotaxis Reports 2024 Full Year Financial Results

Feb 25, 2025, 8:03 AM EST - 5 months ago

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

Feb 14, 2025, 10:41 AM EST - 6 months ago

Stock Market Sleeps On Stereotaxis MAGiC CE Mark

Feb 3, 2025, 4:05 PM EST - 6 months ago

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Jan 30, 2025, 8:09 AM EST - 6 months ago

Stereotaxis Announces First GenesisX Robotic System Order

Jan 27, 2025, 8:00 AM EST - 6 months ago

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

Jan 14, 2025, 7:21 AM EST - 7 months ago

Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology

Dec 9, 2024, 7:25 AM EST - 8 months ago

Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA

Dec 2, 2024, 8:45 AM EST - 8 months ago

Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems

Dec 2, 2024, 5:03 AM EST - 8 months ago

Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025

Nov 26, 2024, 8:28 AM EST - 8 months ago

Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 25, 2024, 8:21 AM EST - 8 months ago

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

Nov 20, 2024, 8:18 AM EST - 9 months ago

Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

Nov 11, 2024, 7:03 PM EST - 9 months ago

Stereotaxis, Inc. (STXS) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 4:02 PM EST - 9 months ago

Stereotaxis Reports 2024 Third Quarter Financial Results

Oct 21, 2024, 8:41 AM EDT - 10 months ago

Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

Sep 9, 2024, 8:40 AM EDT - 11 months ago

Stereotaxis to Present at Upcoming Investor Conferences

Sep 3, 2024, 8:53 AM EDT - 11 months ago

Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX Congress

Aug 25, 2024, 7:22 PM EDT - 1 year ago

Stereotaxis Receives CE Mark For GenesisX, Nears MAGiC Approval

Aug 12, 2024, 11:33 PM EDT - 1 year ago

Stereotaxis, Inc. (STXS) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Stereotaxis Reports 2024 Second Quarter Financial Results

Aug 12, 2024, 4:03 PM EDT - 1 year ago

Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX

Jul 22, 2024, 4:05 PM EDT - 1 year ago

Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024

Jul 18, 2024, 4:13 PM EDT - 1 year ago

Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir

May 29, 2024, 8:25 AM EDT - 1 year ago

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

May 24, 2024, 8:37 AM EDT - 1 year ago

Stereotaxis Receives CE Mark Recertification Under EU's MDR Regulatory Framework

May 23, 2024, 4:38 AM EDT - 1 year ago

Stereotaxis Makes A Strategic Acquisition Bolstering Its Future

May 22, 2024, 8:42 AM EDT - 1 year ago

First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology

May 15, 2024, 8:52 AM EDT - 1 year ago

Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa

May 13, 2024, 7:52 PM EDT - 1 year ago

Stereotaxis, Inc. (STXS) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:03 PM EDT - 1 year ago

Stereotaxis Reports 2024 First Quarter Financial Results

May 13, 2024, 4:02 PM EDT - 1 year ago

Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies

Apr 22, 2024, 7:51 AM EDT - 1 year ago

Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024

Mar 9, 2024, 12:58 AM EST - 1 year ago

Major Regulatory Approvals Coming For Stereotaxis In The Next 10 Months

Mar 4, 2024, 6:57 PM EST - 1 year ago

Stereotaxis, Inc. (STXS) Q4 2023 Earnings Call Transcript

alexpitti Aug. 1 at 4:13 PM

I believe Stereotaxis will be utilizing AI to help procedures in about 3 years which creates a competitive edge versus manual procedures. $STXS

2 · Reply

alexpitti Aug. 1 at 3:47 PM

I believe $STXS will get GenesisX FDA approved in a few weeks and MAGiC FDA approved in 2 months.

0 · Reply

RemitTekram Aug. 1 at 1:38 PM

$STXS Adding...

0 · Reply

alexpitti Jul. 31 at 9:24 PM

Welcome to hell $ABEO $DCTH $STXS $MYO

0 · Reply

Eddypgil Jul. 30 at 8:12 PM

$STXS you could have sold the stock for $6 in 2021 when GenesisX was first announced and bought it today for $2.40

2 · Reply

Eddypgil Jul. 30 at 6:27 PM

$STXS what is last years acquisition APT up to this year?

0 · Reply

Ratman44 Jul. 30 at 4:02 PM

0 · Reply

BillyBeavers Jul. 30 at 3:13 PM

$STXS Why's a $20 stock still on sale for $2

1 · Reply

DecoderRing Jul. 29 at 11:17 PM

0 · Reply

alexpitti Jul. 29 at 11:12 PM

how bad will this earning season be for me? $STXS already pre-announced essentially $DCTH $ABEO $VF $MYO

1 · Reply

NVDAMillionaire Jul. 29 at 5:21 PM

$STXS Excellent article that nails exactly where STXS stands right now. So if you want to update your STXS knowledge or get acquainted with STXS, this is a must read. https://beyondspx.com/article/stereotaxis-unlocking-growth-through-robotic-ecosystem-expansion-stxs

0 · Reply

robh Jul. 29 at 1:59 PM

$STXS I was very skeptical that could make it through the January high and the old adage about it magically coming up about a nickel short of the key resistance holds true once again. I'll pull back yesterday's gap opening of 2.49 that holds on a closing basis probably augments the relative strength aspect for now. Should be interesting to see if it wants to take out 2.71 going into p,m. earnings on the 7th.

1 · Reply

DecoderRing Jul. 29 at 12:12 AM

$STXS I think after being in this stock for over 10 years, most of the news they release is on horrible market days? Anyone else feel that way? Will compound the point that I'm glad its a bit of news with the FDA that is a fact. There is nothing David can do to lie, massage or shade the truth about this. He can't screw this up because its in the records. Fact is fact it was approved and nothing he says about it matters on the next conference call because he will be throwing shade and coloring anything he can- what matters is that it now legal to sell it.

2 · Reply

jacksonjohn750 Jul. 28 at 7:23 PM

$STXS Calls premium says.. it will give back

2 · Reply

RemitTekram Jul. 28 at 6:51 PM

$STXS Glad I didn't sell on the news this morning. That first 30 minutes was brutal.

2 · Reply

d333gs Jul. 28 at 5:49 PM

$STXS Had a great start in 2004

0 · Reply

cheating_stock_investor Jul. 28 at 4:35 PM

$STXS management delivering as expected. Looks like we are also slowly building a more stable shareholder base wont be surprised we see 3 before year end.

2 · Reply

alexpitti Jul. 28 at 3:44 PM

automated mapping with magic sweep sounds like ai to me $STXS

0 · Reply

HolEKa1010 Jul. 28 at 3:38 PM

$STXS can we get this trending?

1 · Reply

robh Jul. 28 at 2:31 PM

$STXS correct me if I'm wrong but it would seem to me that this mapping catheter ties directly in with the May '23 global integration agreement with ABT and their mapping tech....

0 · Reply

Unconditional Jul. 28 at 1:43 PM

$STXS this aged well

1 · Reply

buddyopalosam Jul. 28 at 1:12 PM

$STXS now what. Sell the news?

3 · Reply

Market Cap	190.92M
Revenue (ttm)	26.92M
Net Income (ttm)	-24.05M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-89.34%
Debt to Equity Ratio	0.00

Volume	521,700
Avg Vol	424,088
Day's Range	N/A - N/A
Shares Out	86.00M
Stochastic %K	20%
Beta	1.51
Analysts	Strong Sell
Price Target	$4.50